{"nct_id":"NCT06561386","title":"A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-10-07","start_date_type":"ACTUAL","primary_completion_date":"2030-07-30","primary_completion_date_type":"ESTIMATED","completion_date":"2032-08-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}